Menu Search
Equities

Verrica Pharmaceuticals Inc

1NE:FRA

Verrica Pharmaceuticals Inc

Actions
  • Price (EUR)1.72
  • Today's Change0.148 / 9.44%
  • Shares traded100.00
  • 1 Year change-51.83%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 15:06 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, Verrica Pharmaceuticals Inc increased its cash reserves by 102.92%, or 35.27m. Cash Flow from Financing totalled 74.21m or 1,448.34% of revenues. In addition the company used 38.58m for operations while cash used for investing totalled 362.00k.
Cash flow per share-1.86
Price/Cash flow per share--
Book value per share-0.3133
Tangible book value per share-0.3133
More ▼

Balance sheet in USDView more

Verrica Pharmaceuticals Inc appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 69.55m. In fact, 0.88% of the value of Verrica Pharmaceuticals Inc shares can be attributed to this cash.
Current ratio2.36
Quick ratio2.23
Total debt/total equity--
Total debt/total capital1.42
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.